Paris, France and Camberley, UK – 22 April 2021 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that following the announcement on 9 April 2021, the Company now intends to report its audited financial results for the year ended 31 December 2020 on 29 June 2021. http://novacyt.com/wp-content/uploads/2021/04/Novacyt-Notice-of-Results-22.04.21-ENGLISH.pdf
Visit PageNews and Events
Rapport d’activité
Paris, France et Camberley, Royaume-Uni – 9 avril 2021 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, présente les dernières informations relatives à son contrat d’approvisionnement avec le Ministère de la Santé et des Affaires Sociales britannique (DHSC) et fournit un rapport d’activité non audité pour le trimestre
Visit PageTrading Update
Paris, France and Camberley, UK – 9 April 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its supply contract with the UK Department of Health and Social Care (DHSC) and provides an unaudited trading update for the three months ended 31 March 2021. http://novacyt.com/wp-content/uploads/2021/04/Novacyt-trading-update-09.04.2021.pdf
Visit Page